Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Sr. VP and GM, Life Sciences | June 04, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 12,257 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Tax withholding · Disposed 195 · Balance 12,257 F1: 195 shares were withheld from the 542 restricted shares that vested on June 4, 2026. These 195 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026. F2: As of June 8, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: 195 shares were withheld from the 542 restricted shares that vested on June 4, 2026. These 195 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.
F2: As of June 8, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 8, 2026 20:32 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 195 | $212.24 | $41,386.80 |
DisclosureSEC source: 0001628280-26-041637 · wk-form4_1780950754.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,257 F1 · shares: 195 shares were withheld from the 542 restricted shares that vested on June 4, 2026. These 195 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026. F2 · balance_after: As of June 8, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:32 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 239 | $210.19 | $50,235.41 |
DisclosureSEC source: 0001628280-26-041282 · wk-form4_1780691550.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,452 F1 · shares: 239 shares were withheld from the 666 restricted shares that vested on June 3, 2026. These 239 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 3, 2026. F2 · balance_after: As of June 3, 2026, 4,732 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 8,080 | $0.00 Strike: $230.74 | $0.00 |
DisclosureSEC source: 0001628280-26-040841 · wk-form4_1780605212.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,080 Underlying: Ordinary Shares · 8,080 shares Expires 2036-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,020 on June 2, 2027, 2,020 on June 2, 2028, 2,020 on June 4, 2029 and 2,020 on June 3, 2030. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 127 | $209.76 | $26,639.52 |
DisclosureSEC source: 0001628280-26-040841 · wk-form4_1780605212.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,691 F2 · shares: 127 shares were withheld from the 352 restricted shares that vested on June 2, 2026. These 127 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 5,398 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 666 on June 3, 2026; 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 2,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040841 · wk-form4_1780605212.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,818 F1 · balance_after: As of June 2, 2026, 5,398 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 666 on June 3, 2026; 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:40 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040438 · wk-form4_1780519245.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,502 F1 · shares: 208 shares were withheld from the 578 restricted shares that vested on June 1, 2026. These 208 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 3,425 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,136 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · derivative · entry 6 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,136 shares Expires 2029-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,872 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · derivative · entry 5 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,872 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,136 | $262.00 | $559,632.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 4 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,710 F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 2,136 | $147.05 | $314,098.80 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,872 | $262.00 | $752,464.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,710 F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 2,872 | $114.22 | $328,039.84 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:51 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-044117 · wk-form4_1759524684.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,710 F1 · shares: 52 shares were withheld from the 144 restricted shares that vested on October 1, 2025. These 52 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 144 ordinary shares were awarded to Ms. Madsen on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. F2 · balance_after: As of October 1, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 194 | $242.10 | $46,967.40 |
DisclosureSEC source: 0001628280-25-030033 · wk-form4_1749242065.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,762 F1 · shares: 194 shares were withheld from the 542 restricted shares that vested on June 4, 2025. These 194 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 542 ordinary shares were awarded to Ms. Madsen on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. F2 · balance_after: As of June 4, 2025, 4,147 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:38 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 7,100 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029688 · wk-form4_1749155722.xml · derivative · entry 2 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,100 Underlying: Ordinary Shares · 7,100 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 1,775 on June 3, 2026, 1,775 on June 3, 2027, 1,775 on June 5, 2028 and 1,775 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:38 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029688 · wk-form4_1749155722.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,956 F1 · balance_after: As of June 3, 2025, 4,689 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 127 | $242.08 | $30,744.16 |
DisclosureSEC source: 0001628280-25-029355 · wk-form4_1749069235.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,958 F4 · shares: 127 shares were withheld from the 352 restricted shares that vested on June 2, 2025. These 127 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 352 ordinary shares were awarded to Ms. Madsen on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,700 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 129 | $242.08 | $31,228.32 |
DisclosureSEC source: 0001628280-25-029355 · wk-form4_1749069235.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,085 F3 · shares: 129 shares were withheld from the 360 restricted shares that vested on June 2, 2025. These129 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 360 ordinary shares were awarded to Ms. Madsen on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,700 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 207 | $242.08 | $50,110.56 |
DisclosureSEC source: 0001628280-25-029355 · wk-form4_1749069235.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,214 F1 · shares: 207 shares were withheld from the 578 restricted shares that vested on June 2, 2025. These 207 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 578 ordinary shares were awarded to Ms. Madsen on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,700 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 250 | $235.78 | $58,945.00 |
DisclosureSEC source: 0001628280-24-041922 · wk-form4_1727901248.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,421 F1 · shares: 250 shares were withheld from the 493 restricted shares that vested on October 1, 2024. These 250 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 493 ordinary shares were awarded to Ms. Madsen on October 1, 2020 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 3,990 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,252 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · derivative · entry 6 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,252 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,252 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,252 ordinary shares for $77.07 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · derivative · entry 5 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,700 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 2,700 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 2,700 ordinary shares for $69.72 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,252 | $230.00 | $747,960.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 4 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,671 F1 · balance_after: As of June 5, 2024, 4,483 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 3,252 | $77.07 | $250,631.64 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 400 | $230.00 | $92,000.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,671 Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 400 | $69.72 | $27,888.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:33 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 8,336 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027069 · wk-form4_1717706029.xml · derivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,336 Underlying: Ordinary Shares · 8,336 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 2,084 on June 4, 2025; 2,084 on June 4, 2026; 2,084 on June 4, 2027 and 2,084 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:33 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027069 · wk-form4_1717706029.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,671 F1 · balance_after: As of June 4, 2024, 4,483 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025; 144 on October 1, 2025; 578 on June 1, 2026; 352 on June 2, 2026; 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 126 | $228.37 | $28,774.62 |
DisclosureSEC source: 0001628280-24-026868 · wk-form4_1717619636.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,045 F3 · shares: 126 shares were withheld from the 352 restricted shares that vested on June 3, 2024. These 126 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 352 ordinary shares were awarded to Ms. Madsen on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 2,857 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 129 | $228.37 | $29,459.73 |
DisclosureSEC source: 0001628280-24-026868 · wk-form4_1717619636.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,171 F2 · shares: 129 shares were withheld from the 360 restricted shares that vested on June 3, 2024. These 129 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 360 ordinary shares were awarded to Ms. Madsen on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 44 | $228.37 | $10,048.28 |
DisclosureSEC source: 0001628280-24-026868 · wk-form4_1717619636.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,300 F1 · shares: 44 shares were withheld from the 123 restricted shares that vested on June 3, 2024. These 44 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 207 | $222.88 | $46,136.16 |
DisclosureSEC source: 0001628280-24-026590 · wk-form4_1717533310.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,344 F1 · shares: 207 shares were withheld from the 578 restricted shares that vested on May 31, 2024. These 207 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 578 ordinary shares were awarded to Ms. Madsen on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 3,692 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 171 | $215.50 | $36,850.50 |
DisclosureSEC source: 0001209191-23-051984 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,551 F1 · shares: 171 shares were withheld from the 493 restricted shares that vested on October 2, 2023. These 171 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 493 ordinary shares were awarded to Ms. Madsen on October 1, 2020 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 4,270 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:30 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 247 | $205.47 | $50,751.09 |
DisclosureSEC source: 0001209191-23-034762 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,722 F1 · shares: 247 shares were withheld from the 712 restricted shares that vested on June 2, 2023. These 247 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 712 ordinary shares were awarded to Ms. Madsen on June 2, 2021 and June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2023. F2 · balance_after: As of June 2, 2023, 4,763 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 2, 2023; 144 on October 2, 2023; 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:30 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 43 | $202.42 | $8,704.06 |
DisclosureSEC source: 0001209191-23-034302 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,969 F1 · shares: 43 shares were withheld from the 123 restricted shares that vested on June 1, 2023. These 43 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2023. F2 · balance_after: As of June 1, 2023, 5,475 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Options (right to buy) · Derivative | 9,740 | $0.00 Strike: $219.97 | $0.00 |
DisclosureSEC source: 0001209191-23-033770 · doc4.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,740 Underlying: Ordinary Shares · 9,740 shares Expires 2033-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,435 on May 31, 2024; 2,435 on June 2, 2025; 2,435 on June 1, 2026 and 2,435 on June 1, 2027. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033770 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,012 F2 · balance_after: As of May 31, 2023, 5,598 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 32 | $199.97 | $6,399.04 |
DisclosureSEC source: 0001209191-23-033770 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,278 F1 · shares: 32 shares were withheld from the 92 restricted shares that vested on May 31, 2023. These 32 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 92 ordinary shares were awarded to Ms. Madsen on May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2023. F2 · balance_after: As of May 31, 2023, 5,598 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 171 | $170.07 | $29,081.97 |
DisclosureSEC source: 0001209191-22-052757 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,310 F1 · shares: 171 shares were withheld from the 493 restricted shares that vested on October 3, 2022. These 171 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 493 ordinary shares were awarded to Ms. Madsen on October 1, 2020 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 3,956 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:58 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Options (right to buy) · Derivative | 6,404 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034157 · doc4.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404 Underlying: Ordinary Shares · 6,404 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,601 on June 2, 2023, 1,601 on June 3, 2024, 1,601 on June 2, 2025 and 1,601 on June 2, 2026 Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:58 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034157 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,606 F2 · shares: As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. F2 · balance_after: As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 125 | $227.32 | $28,415.00 |
DisclosureSEC source: 0001209191-22-034533 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,481 F1 · shares: 125 shares were withheld from the 360 restricted shares that vested on June 2, 2022. These 125 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 360 ordinary shares were awarded to Ms. Madsen on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2022. F2 · balance_after: As of June 6, 2022, 4,449 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:58 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 42 | $221.46 | $9,301.32 |
DisclosureSEC source: 0001209191-22-034157 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,198 F1 · shares: 42 shares were withheld from the 123 restricted shares that vested on June 1, 2022. These 42 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022. F2 · balance_after: As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:04 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 72 | $228.20 | $16,430.40 |
DisclosureSEC source: 0001209191-22-033701 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,240 F1 · shares: 72 shares were withheld from the 213 restricted shares that vested on May 31, 2022. These 72 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 213 ordinary shares were awarded to Ms. Madsen on May 31, 2018 and May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 3,524 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:57 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 3,152 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059531 · doc4.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,152 Underlying: Ordinary Shares · 3,152 shares Expires 2031-10-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 788 on October 3, 2022; 788 on October 2, 2023; 788 on October 1, 2024 and 788 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:57 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 121 | $228.36 | $27,631.56 |
DisclosureSEC source: 0001209191-21-059531 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,312 F3 · shares: 121 shares were withheld from the 349 restricted shares that vested on October 1, 2021. These 121 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 349 restricted shares were part of an award of 1,396 ordinary shares that were awarded to Ms. Madsen on October 1, 2020. These vested shares were valued at the NYSE closing market price on October 1, 2021. F2 · balance_after: 3,737 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:57 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059531 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,433 F1 · shares: All 576 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 3, 2022; 144 on October 2, 2023; 144 on October 1, 2024 and 144 on October 1, 2025. F2 · balance_after: 3,737 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:44 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,604 | $0.00 Strike: $210.30 | $0.00 |
DisclosureSEC source: 0001209191-21-037700 · doc4.xml · derivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,604 Underlying: Ordinary Shares · 7,604 shares Expires 2031-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,901 on June 2, 2022; 1,901 on June 2, 2023; 1,901 on June 3, 2024 and 1,901 on June 2, 2025. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:44 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037700 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,857 F1 · shares: All 1,440 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 360 on June 2, 2023; 360 on June 3, 2024 and 360 on June 2, 2025. F2 · balance_after: 3,510 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 June 2, 2023; 349 on October 2, 2023; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024 and 360 on June 2, 2025. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:40 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 43 | $188.43 | $8,102.49 |
DisclosureSEC source: 0001209191-21-037223 · doc4.xml · nonDerivative · entry 4 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,417 F5 · shares: 43 shares were withheld from the 123 restricted shares that vested on June 1, 2021. These 43 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares are part of an award of 492 ordinary shares that were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2021. F2 · balance_after: 2,070 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024 and 349 on October 1, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.